Topics of Crypto World

The fundamental value proposition of ARM stock lies in architecture Approbation, royalties revenue, and ecosystem growth—not chip manufacturing. To fully grasp this, it's essential to assess how Approbation clients, end-product shipments, and the flow of royalties collectively shape ARM's revenue trajectory.

Arm Holdings (ARM) is the stock asset on Gate Stocks representing Arm Holdings plc, with the ticker symbol ARM. Unlike traditional chip manufacturers, Arm is a chip architecture and intellectual property approbation company. Its core value comes from integrating the ARM architecture into a wide range of devices, including smartphones, automobiles, edge computing devices, and data center equipment.

QQQB’s 1:1 real stock reserve outlines asset mapping relationships, but it does not remove Nasdaq 100 volatility, liquidity differences between Binance and DEX, risks related to BSC Smart Contract and self-custody operations, or automatically grant Token Conversion rights across all jurisdictions. Compliance boundaries encompass the issuance structure of BTech Holdings Limited, the ADGM disclosure framework, U.S. broker-dealer custody counterparties, contract address verification, and counterfeit token identification. Prior to operation, four checks must be completed: mechanism, liquidity, on-chain custody, and regional availability.

QQQB (bStocks) represents the Invesco QQQ Trust as a BEP-20 token on BNB Chain, backed by a 1:1 reserve of actual shares. The traditional QQQ ETF is traded directly as shares on the securities market. On the Gate platform, tokenized stocks like gStocks are anchored to real shares and circulate within the order book. While all three instruments provide exposure to the NASDAQ 100, they differ in trading hours, settlement mechanisms, reserve verification methods, and on-chain composability.

QQQB’s 1:1 reserve means every circulating BEP-20 token is fully backed by corresponding underlying capital held by BTech Holdings Limited at a US-regulated brokerage. Proof of Collateral reconciles and publicly discloses circulation and custody holdings daily. Minting and burning must occur in sync with reserve changes. Corporate actions, including stock splits, reverse splits, and dividends, are automatically reflected on-chain via Multiplier rebasing. Minting, burning, or Token Conversion may be paused during designated event windows.

QQQB shares the same underlying asset as the Invesco QQQ Trust (QQQ ETF). Through BTech Holdings Limited, QQQB maintains a 1:1 reserve of actual QQQ Trust shares with a US-regulated broker, providing the economic exposure of QQQ Trust as a BEP-20 token on the BNB Smart Chain. The distinctions between the two are in their form of representation, settlement mechanisms, and rights structure—not in the index they track.

QQQB (Invesco QQQ Trust Tokenized bStocks) is a tokenized equity security that transforms the Invesco QQQ Trust (QQQ ETF) into transferable on-chain units, issued by BTech Holdings Limited. Each BEP-20 token corresponds to the underlying economic interests of the Invesco QQQ Trust (the QQQ ETF tracking the NASDAQ 100) and is backed by a 1:1 real-stock reserve maintained with a regulated U.S. broker. Users can access exposure through Binance spot trading, bidirectional 1:1 fee-free Token Conversion, and on-chain self-custody, with Proof of Collateral ensuring reserve transparency. Corporate actions are managed via Multiplier rebasing, and the token can be utilized within BNB Chain DeFi protocols.

PSK (319660) is the KOSDAQ-listed stock code for PSK Inc., a South Korean manufacturer specializing in semiconductor front-end process equipment and 3D packaging equipment. Spun off from PSK Holdings and listed independently in April 2019, the company is headquartered in Hwaseong, Gyeonggi Province. Its operations span core wafer fabrication processes including Dry Strip and Dry Cleaning, along with the SEMIgear advanced packaging product line.

PSK Inc. (319660) spun off from PSK Holdings in 2019 and went public independently on KOSDAQ. The company specializes in front-end semiconductor equipment, including Dry Strip and Dry Cleaning tools, alongside SEMIgear 3D packaging solutions; on Gate Stocks, the Korea Stock Zones allow users to perform Traders on KRX-listed stocks with settlement in USDT. The ticker 319660 is identical to that on the domestic KOSDAQ market. Regular trading runs from 09:00 to 15:20 KST, with prices shown in KRW and Traders settled in USDT.

Whitechain is WhiteBIT's PoA, EVM-compatible L1, with WBT serving as the native Gas token. For cross-chain transfers, WBT must first be burned on Ethereum or Tron, and an equivalent amount is minted on Whitechain by providing the burn transaction hash. The SoulDrop smart contract allocates the user participation fund and on-chain transaction fees to WB Soul users who both hold WBT Holding and have completed KYC. Rewards are calculated over a 30-day period and compounded based on the user's Holding tier.

On WhiteBIT, completing WBT Holding and earning its benefits is a repeatable process. Users register, deposit, and purchase WBT, then transfer tokens from their main account to the locked Holding account. Based on the amount of tokens held, they activate tier-specific platform benefits. Holding benefits include trading fee discounts, free withdrawals, and Launchpad access. WBT transferred to Holding also counts toward Owning, and both benefit types are stackable.

zkAddress and zkSBT are core privacy identity components developed by Manta Network on the Manta Atlantic chain. zkAddress offers reusable UTXO-style privacy addresses, while zkSBT binds compliance credentials to that address using zero-knowledge proofs. Together, they form the compliant identity infrastructure on the Atlantic chain, enabling Web3 applications to verify identities without revealing users’ original personal data.

Johnson & Johnson (JNJ) is a global healthcare leader based in New Jersey, United States. Established in 1886, the company operates across innovative pharmaceuticals, medical devices, and consumer health, positioning itself as one of the world’s largest general healthcare groups. Over more than a century, Johnson & Johnson has transformed from a traditional medical supplies manufacturer into a global life sciences enterprise, with a core focus on pioneering drug research and advanced medical technologies.

Johnson & Johnson (JNJ) stands as a global leader in healthcare, with its pharmaceutical division, Innovative Medicine, concentrating on high-value therapeutic areas including immune diseases, oncology, neuroscience, cardiovascular, and infectious diseases. The company drives sustained growth through innovative drug development. With the divestiture of its consumer health segment and an increased focus on medical innovation, the pharmaceutical Zones have become the central engine powering JNJ’s future growth.

Johnson & Johnson (JNJ) is a global leader in healthcare, with operations spanning innovative pharmaceutical research and development, medical device manufacturing, and comprehensive health solutions. The company holds a prominent position within the worldwide medical supply chain. In recent years, as artificial intelligence (AI) technology has advanced, Johnson & Johnson has actively pursued AI applications in drug discovery, clinical development, medical data analytics, and patient management, leveraging digital technologies to increase the efficiency of medical innovation.